Puma Biotechnology Q4 Adj EPS $0.43 Beats $0.10 Estimate, Sales $59.10M Beat $52.50M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.10 by 330 percent. This is a 38.71 percent increase over earnings of $0.31 per share from
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.10 by 330 percent. This is a 38.71 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $59.10 million which beat the analyst consensus estimate of $52.50 million by 12.57 percent. This is a 18.14 percent decrease over sales of $72.20 million the same period last year.